Produktbild: Drug Targeting Complexity
Vorbesteller Neu

Drug Targeting Complexity Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

214,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.08.2026

Herausgeber

Lalit Kumar + weitere

Verlag

Elsevier

Seitenzahl

646

Maße (L/B)

23,5/19,1 cm

Gewicht

449 g

Sprache

Englisch

ISBN

978-0-443-43846-2

Beschreibung

Portrait

Lalit Kumar is an Assistant Professor in the Department of Pharmaceutics at the National Institute of Pharmaceutical Education and Research, Hajipur, Vaishali, Bihar, India. His area of research includes the development of nanocarriers for drug-targeting tumor cells in the colon, brain, breast, and lungs.

Dr. Dalapathi Gugulothu working as Assistant professor, Department of Pharmaceutics , Delhi Institute of Pharmaceutical Sciences and Research, Delhi Pharmaceutical Sciences and Research University , New Delhi.

Dr. Sushama Talegaonkar is an Associate Professor at the Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, India. She has approximately 21 years of experience, and has published more than 220 research papers in high impact international journals. Besides this, she has coauthored 6 books and authored 15 chapters in international reference books. Recently, she received the Professor C. J. Shishoo Award for Best Research. Her research paper titled “Development and bioavailability assessment of ramipril nanoemulsion formulation” has received the most cited research paper award on behalf of Elsevier and the board of European Journal of Pharmaceutics and Biopharmaceutics. She was awarded the prestigious Motan Devi Dandiya Biennial Prize for best publication in Pharmaceutical Sciences for the period 2010–11. Dr. Talegaonkar is actively involved in developing a wide variety of smart and functionalized nanodrug delivery systems for targeted anticancer drug delivery.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.08.2026

Herausgeber

Verlag

Elsevier

Seitenzahl

646

Maße (L/B)

23,5/19,1 cm

Gewicht

449 g

Sprache

Englisch

ISBN

978-0-443-43846-2

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Drug Targeting Complexity
  • Part I. Tissue-Specific Targets
    1. Brain-Specific Regulatory T Cell (Treg) Mediators
    2. Liver-Specific Regulatory T Cell Mediators
    3. Lung-Specific Regulatory T Cell Mediators
    4. Adrenal Gland-Specific Regulatory T Cell Mediators
    5. Lymph Node-Specific Regulatory T Cell Mediators
    6. Skin-Specific Regulatory T Cell Mediators
    7. Bone-Specific Regulatory T Cell Mediators
    8. Colon-Specific Regulatory T Cell Mediators
    9. Breast-Specific Regulatory T Cell Mediators

    Part II. Tumor Tissue-Specific Targets
    10. Molecular Targets for Liver Cancer
    11. Molecular Targets for Gastric Cancer
    12. Molecular Targets for Breast Cancer
    13. Molecular Targets for Ovarian Cancer
    14. Molecular Targets in Prostate Cancer
    15. Molecular Targets in Colon Cancer
    16. Molecular Targets in Lung Cancer
    17. Molecular Targets in Blood Cancer

    Part III. Advanced Therapeutic Approaches
    18. Human Genetic Mutation-Based Targeting
    19. Microbiome in Cancer Immunotherapy and Cancer Progression
    20. Precision Medicine
    21. Future Directions and Challenges in Cancer Targeting Therapies